University of Michigan researchers have created a new mouse model that closely mirrors liposarcoma, a rare and hard-to-treat soft tissue cancer. In a Q&A, surgical oncologist Christina V. Angeles, M.D., explains how it captures the same genetic and immune features seen in patients. After decades of limited progress, the model offers researchers at U-M and across the country a powerful way to test new drug combinations before they move to clinical trials.
